Meanwhile, all directors of CDC Software International, except for John Clough now its CEO, were removed on January 11 by CDC Corp.  A shareholders meeting is being called to consider removing all CDC Software directors and to block the sale. CDC Corp. is the parent of publicly traded CDC Software and International owns 98 percent of the voting stock of that unit. (Don't ask me to explain this.) You may remember a $65 million judgment was levied against CDC Software and there was a bizarre removal of its CEO Peter Yip after he was found to have lied under oath. But he was then reinstated and placed on medical leave. That spurred NASDAQ to delist the company's stock. Shareholders would also consider appointing restructuring officer, Marc Watson; Joseph D. Stutz, general counsel for CDC Corp.; and Dwight Mamanteo as directors of CDC Software (which would seem to place CDC Software on a very short leash.) The latter is a portfolio manager for Wynnefield Capital, a major shareholder. This got started because over Watson’s objection, management reached an agreement to sell Ross and Tradebeam to Marlin Equity Partners or Marlin Management Company, for $60 million. CDC Software would be required to advance Malin $150,000 for expenses, with another $150,000 ready on request.